Non-alcoholic fatty liver disease and the metabolic syndrome: Effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer
Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of fat-induced liver injury, ranging from relatively benign steatosis to cirrhosis and liver failure. The presence of obesity and insulin resistance is strongly associated with non-alcoholic fatty liver and confers on it a greater...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 12; no. 3; pp. 345 - 353 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Division of Gastroenterology Hepatology, Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut, United States
21.01.2006
Baishideng Publishing Group Co., Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of fat-induced liver injury, ranging from relatively benign steatosis to cirrhosis and liver failure. The presence of obesity and insulin resistance is strongly associated with non-alcoholic fatty liver and confers on it a greater risk of histologically advanced disease. There is a growing concern in the medical profession as the prevalence of this disease continues to rise in parallel with the rise in obesity and the metabolic syndrome. Treatment options are limited and dietary weight loss is often advised. Low fat diets are difficult to adhere to and recent studies have shown the potential of low carbohydrate diets for weight loss and improving insulin resistance. Thus far, no study has evaluated the effect of low carbohydrate diets on NAFLD. Future studies will be required to address this question and others with regards to the nutritional adequacy and long-term side effects of these diets. |
---|---|
Bibliography: | Obesity Diet management 14-1219/R R575.5 Non-alcoholic fatty liver disease Metabolic syndrome Non-alcoholic fatty liver disease; Obesity;Metabolic syndrome; Diet management SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 Correspondence to: George Y Wu, MD, PhD, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut, 06030-1845, United States. wu@nso.uchc.edu Telephone: +860-679-3158 Fax: +860-679-3159 |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v12.i3.345 |